CN Patent

CN117924325A — 一种抗流感病毒衍生物及其用途

Assigned to Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd · Expires 2024-04-26 · 2y expired

What this patent protects

本发明公开了一种高效抗病毒衍生物及其用途；所述的衍生物为如下式(I)所示的化合物或其水合物、溶剂化物、光学异构体、多晶型物、同位素衍生物、药学上可接受的盐，此外还公开了该衍生物的制备方法。本发明的化合物可以用于制备预防/治疗流感病毒的药物。

USPTO Abstract

本发明公开了一种高效抗病毒衍生物及其用途；所述的衍生物为如下式(I)所示的化合物或其水合物、溶剂化物、光学异构体、多晶型物、同位素衍生物、药学上可接受的盐，此外还公开了该衍生物的制备方法。本发明的化合物可以用于制备预防/治疗流感病毒的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN117924325A
Jurisdiction
CN
Classification
—
Expires
2024-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.